6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	Data I/O to Present at the Planet MicroCap Investor Conference Powered by MicroCapClub
Just now	Rapid7 Q1 2026 Threat Landscape Report Finds Vulnerability Exploitation Overtakes Social Engineering as the Top Initial Access Vector
Just now	Jamal Satli Iglesias, Marriott International and Aimbridge Hospitality Announce Landmark All-Inclusive Resort in Riviera Maya
1m ago	Chevron Introduces Next-gen Techron in U.S. Chevron and Texaco Gasolines
1m ago	GreenPower Unveils Innovative Heating Solution for Type A Nano BEAST All-Electric, Purpose-Built, Zero-Emission School Bus

About

2.21USD+0.13 +6.25%

Closed • Updated at 13:35 GMT+00:00

Market Cap$145.54M

Volume174.7K

Beta-0.75

RSI45.94

Health TechnologyBiotechnology

Galectin Therapeutics Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update

Galectin Therapeutics Announces Publication of NAVIGATE Phase 2b Trial Results for Belapectin in the Journal of Hepatology

Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update

Galectin Therapeutics Strengthens Board of Directors with Appointment of Henry Brem, M.D.

Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin Development Program for Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Cirrhosis and Portal Hypertension, on March 10, 2026 at 12:00 PM ET

Community Chat

Ask AI